Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular

Status Recruiting

Clinical Trial Summary

The performance of keratoplasty is hampered by the limited availability of donor cornea in many countries, especially in Asia. For this reason, attempts have been made to fabricate artificial substitutes for natural human cornea. So far, all polymeric biomaterials, such as collagen configurations and plastic compression, could mimic the functional optically transparent but failed to replicate the complicate three-dimension microstructure of natural cornea. Therefore, despite some favorable results yielded by polymeric biomaterials, they cannot be suited for long-term use. To overcome these disadvantages, in recent years, porcine cornea appeared specifically attractive for xenotransplantation, because of its accessibility and similarities to natural human cornea. However, xenotransplantation using fresh porcine cornea can occurs hyperacute immune rejection, resulting in graft failure. Such transplant rejection can be substantially lessened by using acellular porcine cornea (APC), which preserves the constructure of natural cornea, whilst having well biocompatibility and low antigenicity. These properties feature APC particularly suitable for high-risk keratoplasty, such as corneal grafting in infectious keratitis.

Use of APC in LK has been shown promise in many preclinical animal studies and initially in human clinic trail. However, to optimize APC biological and biomechanical properties, the strategies for its preparation has evolved extensively over recent years, like various decellularization approaches (e.g. detergents, enzymes, human sera, hypertonic solutions and et al) and additional procedures (e.g. collagen re-crosslinking and repeated frozen-dry). Therefore, in the current study, the investigators analyzed the early surgical outcomes of deep anterior lamellar keratoplasty (DALK) using the APC that was very recently approved by the National Institutes for Food and Drug Control (NIFDC) of China for clinic practice, for management of infective keratitis, including fungal, viral and acanthamoeba keratitis. Here major concern of this study was to clarify the behavior of APC after implantation in participants.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Corneal Transplantation

Clinical Trial Details

NCT number	NCT03105466
Study type	Interventional
Source	Zhongshan Ophthalmic Center, Sun Yet-san University
Contact
Status	Recruiting
Phase	N/A
Start date	February 2016
Completion date	February 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01206127` - DSAEK- Postoperative Positioning and Transplant Dislocation	N/A
Terminated	`NCT00764582` - Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery	Phase 4
Recruiting	`NCT05870566` - Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision]	N/A
Recruiting	`NCT02084745` - Timing of Glaucoma Drainage Device With Boston Keratoprosthesis	N/A
Unknown status	`NCT00834782` - Comparison of DCT, ORA and GAT in Eyes After Penetrating Keratoplasty	Phase 4
Withdrawn	`NCT00345020` - Deep Lamellar Endothelial Keratoplasty: Small Incision Technique
Completed	`NCT00000137` - Collaborative Corneal Transplantation Studies (CCTS)	Phase 3
Recruiting	`NCT04339907` - Inflammatory Mediators of Glaucoma After Corneal Transplantation (AH-Tears)	N/A
Active, not recruiting	`NCT00874835` - Corneal Endothelium Delivery Instrument	Phase 2
Completed	`NCT00570648` - A Prospective Study of the Effect of Topical Sodium Hyaluronate Immediately Post-PKP on Time to Reepithelialization	N/A
Enrolling by invitation	`NCT03461978` - Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures	N/A
Not yet recruiting	`NCT05210478` - Intraoperative Optical Coherence Tomography for Ophthalmic Surgical Guidance - Cornea
Completed	`NCT01694914` - Comparative Study of Two Corneal Graft Storage Media: New Animal Compound Free Medium Versus Reference Medium	Phase 3
Completed	`NCT03381794` - The German Keratoplasty Registry of the German Ophthalmological Society (DOG)	N/A
Completed	`NCT00409656` - Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients	Phase 2
Recruiting	`NCT01018888` - Safety and Efficacy Study of Artificial Cornea	Phase 4
Recruiting	`NCT04490902` - Clinical Study on the Treatment of Mixed Component Cornea for High Risk Keratoplasty	N/A
Recruiting	`NCT04337944` - Endoscopic Assisted Anterior Hyaloid Peeling in Boston Type 1 Keratoprosthesis (KPro-HP-Endo)	N/A
Completed	`NCT01547975` - Retrospective Analysis of Surgical Outcomes After Corneal Transplantation	N/A
Terminated	`NCT00447642` - Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine Cornea

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms